The Optimal Treatment for Stage IIIA-N2 Non-small-cell Lung Cancer: A Network Meta-analysis

ANNALS OF THORACIC SURGERY, pp. 1866-1875, 2018.

Cited by: 1|Bibtex|Views12|

Abstract:

Background. The optimal treatment for stage IIIA-N2 non-small cell lung cancer (NSCLC) is controversial. We aimed to address this important issue through a Bayesian network meta-analysis. Methods. We performed a search of electronic databases for randomized controlled trials comparing the following treatments: surgery, radiotherapy, chemo...More

Code:

Data:

Your rating :
0

 

Tags
Comments